SOPHiA GENETICS (SOPH) Shares Outstanding (2020 - 2026)

SOPHiA GENETICS has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $1.4 billion in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 2.24% year-over-year to $1.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 billion (up 2.24% YoY) and the FY2025 annual result came in at $1.4 billion, up 2.24% from the prior year.
• Shares Outstanding (Entity) steadied at $1.4 billion in Q4 2025 per SOPH's latest filing, from $1.3 billion in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $1.4 billion in Q4 2025 and troughed at $1.1 billion in Q4 2021.
• A 5-year average of $1.3 billion and a median of $1.3 billion in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Entity) jumped 30.58% in 2021, then gained 0.55% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $1.1 billion in 2021, then advanced by 15.91% to $1.3 billion in 2022, then rose by 1.02% to $1.3 billion in 2023, then gained by 2.03% to $1.3 billion in 2024, then grew by 2.24% to $1.4 billion in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.4 billion, $1.3 billion, and $1.3 billion for Q4 2025, Q2 2025, and Q4 2024 respectively.